Invesco Biotechnology & Genome ETF
PBE
PBE
73 hedge funds and large institutions have $129M invested in Invesco Biotechnology & Genome ETF in 2014 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.41% less ownership
Funds ownership: 32.49% → 31.08% (-1.4%)
Holders
73
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.29M | |
| 2 | +$4.12M | |
| 3 | +$3.31M | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$3.22M |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$2.63M |
Top Sellers
| 1 | -$6.69M | |
| 2 | -$632K | |
| 3 | -$274K | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$259K |
| 5 |
B
Baird
Milwaukee,
Wisconsin
|
-$210K |